drugset / Trial / NCT00375206

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

NCT00375206 ↗

Phase 1 Completed 189 enrolled PowderMed
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate how well the vaccine is tolerated at sites where administrations are given and any effects it may have on subjects' wellbeing. The study will also test the ability of vaccine to cause particular immune responses in the body.

Timeline

Start
2006-09
Primary completion
—
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DEI-LT Unknown — —
Subject PIA0601 Vaccine — Other

Indications